Company-level financial information
UNIVERSAL HEALTH SERVICES INC
Selected annual earnings and cash-flow facts from SEC filings. Each row identifies its exact reporting period and original filing.
Annual net income
| Reporting period | Measure | USD millions | Filing |
|---|---|---|---|
| Dec 31, 2025From Jan 1, 2025 | Operating cash flow | 1,864.4 | SEC filingFeb 25, 2026 |
| Dec 31, 2025From Jan 1, 2025 | Net income | 1,488.8 | SEC filingFeb 25, 2026 |
| Dec 31, 2025From Jan 1, 2025 | Common-stock cash dividends | 51.3 | SEC filingFeb 25, 2026 |
| Dec 31, 2025From Jan 1, 2025 | Capital expenditures (PP&E) | 1,015.2 | SEC filingFeb 25, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Operating cash flow | 2,067.1 | SEC filingFeb 25, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Net income | 1,142.1 | SEC filingFeb 25, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Common-stock cash dividends | 53.3 | SEC filingFeb 25, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Capital expenditures (PP&E) | 943.8 | SEC filingFeb 25, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Operating cash flow | 1,267.8 | SEC filingFeb 25, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Net income | 717.8 | SEC filingFeb 25, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Common-stock cash dividends | 55.5 | SEC filingFeb 25, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Capital expenditures (PP&E) | 743.1 | SEC filingFeb 25, 2026 |
| Dec 31, 2022From Jan 1, 2022 | Operating cash flow | 996.0 | SEC filingFeb 26, 2025 |
| Dec 31, 2022From Jan 1, 2022 | Net income | 675.6 | SEC filingFeb 26, 2025 |
| Dec 31, 2022From Jan 1, 2022 | Common-stock cash dividends | 58.4 | SEC filingFeb 26, 2025 |
| Dec 31, 2022From Jan 1, 2022 | Capital expenditures (PP&E) | 734.0 | SEC filingFeb 26, 2025 |
| Dec 31, 2021From Jan 1, 2021 | Operating cash flow | 883.7 | SEC filingFeb 27, 2024 |
| Dec 31, 2021From Jan 1, 2021 | Net income | 991.6 | SEC filingFeb 27, 2024 |
| Dec 31, 2021From Jan 1, 2021 | Common-stock cash dividends | 65.9 | SEC filingFeb 27, 2024 |
| Dec 31, 2021From Jan 1, 2021 | Capital expenditures (PP&E) | 855.7 | SEC filingFeb 27, 2024 |
| Dec 31, 2020From Jan 1, 2020 | Operating cash flow | 2,360.2 | SEC filingFeb 27, 2023 |
| Dec 31, 2020From Jan 1, 2020 | Net income | 944.0 | SEC filingFeb 27, 2023 |
| Dec 31, 2020From Jan 1, 2020 | Common-stock cash dividends | 17.3 | SEC filingFeb 27, 2023 |
| Dec 31, 2020From Jan 1, 2020 | Capital expenditures (PP&E) | 731.3 | SEC filingFeb 27, 2023 |
| Dec 31, 2019From Jan 1, 2019 | Operating cash flow | 1,438.5 | SEC filingFeb 24, 2022 |
| Dec 31, 2019From Jan 1, 2019 | Net income | 814.9 | SEC filingFeb 24, 2022 |
| Dec 31, 2019From Jan 1, 2019 | Common-stock cash dividends | 53.0 | SEC filingFeb 24, 2022 |
| Dec 31, 2019From Jan 1, 2019 | Capital expenditures (PP&E) | 634.1 | SEC filingFeb 24, 2022 |